The American Society for Colposcopy and Cervical Pathology (ASCCP) has issued new guidelines reflecting the importance of extended genotyping in HPV testing to support an enhanced standard of patient ...

Short-interval HPV retesting showed promise for identifying high-risk cervical neoplasia in HPV-positive patients. A positive repeat HPV test at 2 months had 82-88% sensitivity for high-grade cervical ...

Men with high-risk HPV had significantly higher levels of sperm necrosis; increased proportions of ROS-positive spermatozoa. (HealthDay News) — Comprehensive human papillomavirus (HPV) screening, ...

According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...

Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...

Following the 2024 FDA approval of a new self-collection test to detect HPV, the U.S. Preventive Services Task Force ...

In this webinar, Jenny Meredith, Ph.D., HCLD(ABB), Clinical Microbiology Director at Prisma Health-Upstate joins forces with Sara Ezra, Molecular Supervisor at Pathology Consultants (subsidiary of ...

In a clinical study designed to detect human papillomavirus (HPV) E6/E7 mRNA in routine clinical specimens of head and neck cancer, HPV status determined by the RNAscope HPV test was highly predictive ...

Effect of Hospital Teaching Status on Mortality and In-Hospital Outcomes in Patients Hospitalized With Acute Leukemia: A National Study Study was carried out from a cohort of study participants in the ...

ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...